Skip to main content

Archive

Pfizer Astrazeneca: Marketing an Acquisition (Parts A & B)

In 2014, Pfizer proposed a friendly acquisition of AstraZeneca, but the AstraZeneca board resisted over price and strategy concerns. Was this good for pharmaceutical consumers? Pfizer, like pharmaceutical companies in general, faced difficulties in…

Filter Cases

Author affiliation
Geographic focus
Case keywords
Case availability & pricing
Case discipline/subject
Health condition
Diversity and identity
Supplemental teaching material